The series B fundraising will support the clinical development of next-generation multivalent vaccines against respiratory ...

The US FDA previously granted fast track designation for fasedienol for the acute treatment of social anxiety disorder. Credit: mojo cp / Shutterstock. US-based biopharmaceutical company Vistagen has ...

The trial investigated the efficacy and safety of a once-daily 10-mg, 20-mg, and 50-mg dose of monlunabant vs. placebo on body weight after 16 weeks in 243 people with obesity and metabolic syndrome.

"Vicebio secures $100m to advance RSV and hMPV vaccine combo to Phase I" was originally created and published by ...

Vicebio has secured $100mn in Series B funding to further develop its vaccines for multiple respiratory infections.

British biotech Vicebio has secured $100 million in a series B funding round to advance its next-generation vaccines against ...

Actinium reported data from the Phase III SIERRA trial of Iomab-B for relapsed or refractory acute myeloid leukaemia (r/r AML ...

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

The respiratory syncytial virus (RSV) space may have filled up over the past year, but that isn’t deterring Vicebio or its ...

Vicebio Ltd ("Vicebio"), a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral infections, today announces a $100 million Series B financing led by TCGX with ...

The company said it is “very confident in Arexvy, which has a best-in class profile, including the highest efficacy (94 per ...

Laurentian Bank of Canada announces a decrease to its base rate in Canada of 50 basis points from 9.00% to 8.50%, effective September 19, 2024. About Laurentian Bank Founded in Montréal in 1846, ...